A Study to Evaluate JAK Inhibitor Cream in EGFR-inhibitor-induced Skin Rash
Condition(s):Acneiform EruptionsLast Updated:March 2, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Acneiform EruptionsLast Updated:March 2, 2023Active, not recruiting
Condition(s):Systemic Sclerosis; Interstitial Lung DiseaseLast Updated:August 3, 2023Recruiting
Condition(s):Dermatomyositis, Adult TypeLast Updated:July 19, 2021Unknown status
Condition(s):Rheumatoid ArthritisLast Updated:February 7, 2024Recruiting
Condition(s):Colitis, UlcerativeLast Updated:December 22, 2022Recruiting
Condition(s):Rheumatoid Arthritis; Inflammatory Rheumatism; Psoriatic Arthritis; SpondyloarthritisLast Updated:October 26, 2022Recruiting
Condition(s):Abatacept; Treatment Compliance; Rheumatoid ArthritisLast Updated:September 23, 2022Recruiting
Condition(s):Primary Myelofibrosis; Secondary MyelofibrosisLast Updated:March 5, 2024Active, not recruiting
Condition(s):Arthritis, Rheumatoid; Arthritis, Psoriatic; SpondyloarthritisLast Updated:March 29, 2021Recruiting
Condition(s):Dermatitis, AtopicLast Updated:May 28, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.